Collaboration through the ACTIV partnership is critical for success & FDA will continue to use every tool possible under our #Coronavirus Treatment Acceleration Program to speed the development of safe & effective medical countermeasures. https://twitter.com/NIH/status/1251134603894484997   …

Collaboration through the ACTIV partnership is critical for success & FDA will continue to use every tool possible under our #Coronavirus Treatment Acceleration Program to speed the development of safe & effective medical countermeasures. https://twitter.com/NIH/status/1251134603894484997 …
Source: Food and Drug Adminstration (FDA): CDRHNew - Category: Medical Devices Authors: Source Type: news